BRPI0913697A2 - lesão de medula, inflamação e doença auto-imuni: agentes teraupêuticos de liberação local controlada. - Google Patents
lesão de medula, inflamação e doença auto-imuni: agentes teraupêuticos de liberação local controlada.Info
- Publication number
- BRPI0913697A2 BRPI0913697A2 BRPI0913697A BRPI0913697A BRPI0913697A2 BR PI0913697 A2 BRPI0913697 A2 BR PI0913697A2 BR PI0913697 A BRPI0913697 A BR PI0913697A BR PI0913697 A BRPI0913697 A BR PI0913697A BR PI0913697 A2 BRPI0913697 A2 BR PI0913697A2
- Authority
- BR
- Brazil
- Prior art keywords
- inflammation
- therapeutic agents
- spinal cord
- autoimmune disease
- cord injury
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10012708P | 2008-09-25 | 2008-09-25 | |
PCT/US2009/058479 WO2010036961A1 (en) | 2008-09-25 | 2009-09-25 | Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0913697A2 true BRPI0913697A2 (pt) | 2016-10-11 |
Family
ID=42060110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0913697A BRPI0913697A2 (pt) | 2008-09-25 | 2009-09-25 | lesão de medula, inflamação e doença auto-imuni: agentes teraupêuticos de liberação local controlada. |
Country Status (9)
Country | Link |
---|---|
US (4) | US20100196481A1 (pt) |
EP (1) | EP2346515A4 (pt) |
JP (2) | JP5529874B2 (pt) |
KR (2) | KR20130056348A (pt) |
CN (1) | CN102858353A (pt) |
AU (1) | AU2009296394B2 (pt) |
BR (1) | BRPI0913697A2 (pt) |
CA (1) | CA2738766A1 (pt) |
WO (1) | WO2010036961A1 (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102858353A (zh) * | 2008-09-25 | 2013-01-02 | 英伟活康复医疗有限公司 | 脊髓损伤、炎症和免疫性疾病:治疗剂的局部控释 |
TWI461193B (zh) * | 2009-07-24 | 2014-11-21 | Taipei Veterans General Hospital | 水飛薊或水飛薊賓用於治療神經受損之用途 |
DE102010034331A1 (de) * | 2010-08-14 | 2012-02-16 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Polymer-gestützte Kultursysteme |
TW201313263A (zh) | 2011-07-13 | 2013-04-01 | Invivo Therapeutics Corp | 聚乳酸-聚乙醇酸(plga)-b-離胺酸及plga與pll(聚e-cbz-l離胺酸)嵌段共聚物合成方法 |
JP6170047B2 (ja) | 2011-08-31 | 2017-07-26 | ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド | アポトーシス−ターゲティングナノ粒子 |
US20130142781A1 (en) * | 2011-12-02 | 2013-06-06 | Invivo Therapeutics Corporation | Peg based hydrogel for peripheral nerve injury applications and compositions and method of use of synthetic hydrogel sealants |
US20150000936A1 (en) * | 2011-12-13 | 2015-01-01 | Schlumberger Technology Corporation | Energization of an element with a thermally expandable material |
WO2013123298A1 (en) | 2012-02-17 | 2013-08-22 | University Of Georgia Research Foundation, Inc. | Nanoparticles for mitochondrial trafficking of agents |
WO2013134760A2 (en) * | 2012-03-09 | 2013-09-12 | Invivo Therapeutics Corporation | Protective packaging with product preparation features incorporated |
US20140271601A1 (en) * | 2013-03-13 | 2014-09-18 | Invivo Therapeutics Corporation | Crosslinkable trehalose for the covalent incorporation in hydrogels and methods of use |
WO2014152790A1 (en) | 2013-03-14 | 2014-09-25 | Drexel University | Chelated drug delivery systems |
US9865434B2 (en) * | 2013-06-05 | 2018-01-09 | Applied Materials, Inc. | Rare-earth oxide based erosion resistant coatings for semiconductor application |
PL3088353T3 (pl) * | 2013-12-27 | 2020-07-13 | Bilix Co., Ltd. | Cząstki bilirubiny i ich wytwarzanie do zastosowania w terapii |
CN103751102A (zh) * | 2014-01-15 | 2014-04-30 | 上海交通大学 | 一种胶原酶温敏水凝胶及其制备方法和应用 |
US10398663B2 (en) | 2014-03-14 | 2019-09-03 | University Of Georgia Research Foundation, Inc. | Mitochondrial delivery of 3-bromopyruvate |
CN107073112A (zh) * | 2014-08-15 | 2017-08-18 | 皮克萨尔比奥公司 | 用于在患有脊髓损伤的对象中抑制炎症的组合物及其使用方法 |
US20170304453A1 (en) * | 2014-09-05 | 2017-10-26 | Massachusetts Institute Of Technology | Thiol-ene functionalized hydrogels |
US11065272B2 (en) | 2015-10-06 | 2021-07-20 | University Of Washington | Oxygen reactive polymers for treatment of traumatic brain injury |
KR101670249B1 (ko) * | 2016-02-16 | 2016-10-31 | (주) 메디프레소 | 항암제 약물전달체 및 이의 제조방법 |
WO2018067948A1 (en) * | 2016-10-07 | 2018-04-12 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Biodegradable, antioxidant, thermally responsive injectable hydrogel and uses therefor |
US11911504B2 (en) | 2018-02-02 | 2024-02-27 | Galen Therapeutics Llc | Apparatus and method for protecting neurons and reducing inflammation and scarring |
US20210220266A1 (en) * | 2018-07-20 | 2021-07-22 | The Hong Kong University Of Science And Technology | Compositions and methods for controlled release of target agent |
KR102129986B1 (ko) * | 2018-08-30 | 2020-07-03 | 포항공과대학교 산학협력단 | 일산화질소 감응성을 갖는 아크릴아마이드계 고분자를 포함하는 염증성 질환 예방 또는 치료용 약학 조성물 |
US20210100909A1 (en) * | 2019-10-07 | 2021-04-08 | United States Government As Represented By The Department Of Veterans Affairs | Polymeric Methylprednisolone Conjugates and Uses Thereof |
KR102479259B1 (ko) | 2020-06-10 | 2022-12-22 | 주식회사 셀진 | 손상된 조직 부위에 주사 가능한 하이드로겔 및 이의 용도 |
WO2022093903A1 (en) * | 2020-10-28 | 2022-05-05 | New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery | Methods and compositions for nutritional sustenance and waste scavenging in tissue injuries and wounds |
CN112933293B (zh) * | 2020-11-06 | 2022-06-10 | 浙江大学 | 一种治疗中枢神经损伤的可注射水凝胶及其制备方法 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6309635B1 (en) * | 1986-11-20 | 2001-10-30 | Children's Medical Center Corp. | Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo |
US5804178A (en) * | 1986-11-20 | 1998-09-08 | Massachusetts Institute Of Technology | Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue |
CA1340581C (en) * | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
US5265608A (en) * | 1990-02-22 | 1993-11-30 | Medtronic, Inc. | Steroid eluting electrode for peripheral nerve stimulation |
US6352707B1 (en) * | 1992-02-24 | 2002-03-05 | Anton-Lewis Usala | Transplant encapsulation in a hydrogel matrix to obscure immune recognition |
CA2144407C (en) * | 1992-09-10 | 2000-05-30 | Charles B. Berde | Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
US6689608B1 (en) * | 1993-02-01 | 2004-02-10 | Massachusetts Institute Of Technology | Porous biodegradable polymeric materials for cell transplantation |
US5514378A (en) * | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
US6281015B1 (en) * | 1994-12-16 | 2001-08-28 | Children's Medical Center Corp. | Localized delivery of factors enhancing survival of transplanted cells |
US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US5654381A (en) * | 1995-06-16 | 1997-08-05 | Massachusetts Institute Of Technology | Functionalized polyester graft copolymers |
US6095148A (en) * | 1995-11-03 | 2000-08-01 | Children's Medical Center Corporation | Neuronal stimulation using electrically conducting polymers |
US6004573A (en) * | 1997-10-03 | 1999-12-21 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
US6958212B1 (en) * | 1999-02-01 | 2005-10-25 | Eidgenossische Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
US6103255A (en) * | 1999-04-16 | 2000-08-15 | Rutgers, The State University | Porous polymer scaffolds for tissue engineering |
US6333029B1 (en) * | 1999-06-30 | 2001-12-25 | Ethicon, Inc. | Porous tissue scaffoldings for the repair of regeneration of tissue |
KR100446101B1 (ko) * | 2000-12-07 | 2004-08-30 | 주식회사 삼양사 | 수난용성 약물의 서방성 제형 조성물 |
CA2365376C (en) * | 2000-12-21 | 2006-03-28 | Ethicon, Inc. | Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
DE10064195A1 (de) * | 2000-12-22 | 2002-07-11 | Migragen Ag | Verwendung einer Zusammensetzung zur Stimulation des Nervenwachstums, zur Inhibition der Narbengewebsbildung und/oder Reduktion eines Sekundärschadens |
US20030232091A1 (en) * | 2002-06-17 | 2003-12-18 | Adi Shefer | Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof |
US7101566B2 (en) * | 2002-06-28 | 2006-09-05 | Ethicon, Inc. | Polymer coated microparticles for sustained release |
US7402319B2 (en) * | 2002-09-27 | 2008-07-22 | Board Of Regents, The University Of Texas System | Cell-free tissue replacement for tissue engineering |
AU2003293082A1 (en) * | 2002-11-27 | 2004-06-23 | Tufts University | Antioxidant-functionalized polymers |
US7641643B2 (en) * | 2003-04-15 | 2010-01-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
US20050025804A1 (en) * | 2003-07-28 | 2005-02-03 | Adam Heller | Reduction of adverse inflammation |
US7846466B2 (en) * | 2004-06-10 | 2010-12-07 | Northwestern University | Biodegradable scaffolds and uses thereof |
WO2006023530A2 (en) * | 2004-08-16 | 2006-03-02 | Massachusetts Institute Of Technology | Compositions and methods for enhancing structural and functional nervous system reorganization and recovery |
US20060178554A1 (en) * | 2005-02-04 | 2006-08-10 | Mandel Shlomo S | Nerve protection barrier |
US7638558B2 (en) * | 2005-04-01 | 2009-12-29 | Intezyne Technologies, Inc. | Polymeric micelles for drug delivery |
JP2008535847A (ja) * | 2005-04-08 | 2008-09-04 | サーモディクス,インコーポレイティド | 網膜下に送達するための持続放出インプラント |
US7767656B2 (en) * | 2005-04-25 | 2010-08-03 | Molly S Shoichet | Blends of temperature sensitive and anionic polymers for drug delivery |
MX2008000088A (es) * | 2005-06-29 | 2008-03-18 | Saint Gobain Abrasives Inc | Resina de alto desempeno para productos abrasivos. |
WO2007041677A2 (en) * | 2005-10-03 | 2007-04-12 | Combinatorx, Incorporated | Soft tissue implants and drug combination compositions, and use thereof |
EP2599858A3 (en) * | 2006-01-27 | 2013-09-18 | The Regents of The University of California | Biomimetic scaffolds |
US8267918B2 (en) * | 2006-03-14 | 2012-09-18 | Kci Licensing, Inc. | System and method for percutaneously administering reduced pressure treatment using a flowable manifold |
US20100040609A1 (en) * | 2006-07-07 | 2010-02-18 | Gorman James R | Methods for preventing, postponing or improving the outcome of invasive spinal procedures |
CN102858353A (zh) * | 2008-09-25 | 2013-01-02 | 英伟活康复医疗有限公司 | 脊髓损伤、炎症和免疫性疾病:治疗剂的局部控释 |
-
2009
- 2009-09-25 CN CN2009801446943A patent/CN102858353A/zh active Pending
- 2009-09-25 KR KR1020137009934A patent/KR20130056348A/ko not_active Application Discontinuation
- 2009-09-25 AU AU2009296394A patent/AU2009296394B2/en not_active Ceased
- 2009-09-25 US US12/567,589 patent/US20100196481A1/en not_active Abandoned
- 2009-09-25 BR BRPI0913697A patent/BRPI0913697A2/pt not_active IP Right Cessation
- 2009-09-25 JP JP2011529282A patent/JP5529874B2/ja not_active Expired - Fee Related
- 2009-09-25 WO PCT/US2009/058479 patent/WO2010036961A1/en active Application Filing
- 2009-09-25 KR KR1020117009223A patent/KR101368736B1/ko not_active IP Right Cessation
- 2009-09-25 CA CA2738766A patent/CA2738766A1/en not_active Abandoned
- 2009-09-25 EP EP09816952A patent/EP2346515A4/en not_active Withdrawn
-
2013
- 2013-08-08 US US13/962,486 patent/US20130324509A1/en not_active Abandoned
- 2013-08-08 US US13/962,459 patent/US20130324500A1/en not_active Abandoned
- 2013-08-27 JP JP2013175644A patent/JP2013234205A/ja active Pending
-
2014
- 2014-11-26 US US14/554,548 patent/US20150148317A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2013234205A (ja) | 2013-11-21 |
AU2009296394A1 (en) | 2010-04-01 |
CN102858353A (zh) | 2013-01-02 |
JP2012506840A (ja) | 2012-03-22 |
CA2738766A1 (en) | 2010-04-01 |
EP2346515A4 (en) | 2013-01-23 |
WO2010036961A1 (en) | 2010-04-01 |
KR20130056348A (ko) | 2013-05-29 |
US20130324509A1 (en) | 2013-12-05 |
EP2346515A1 (en) | 2011-07-27 |
US20100196481A1 (en) | 2010-08-05 |
AU2009296394B2 (en) | 2014-01-09 |
KR20110081209A (ko) | 2011-07-13 |
US20150148317A1 (en) | 2015-05-28 |
JP5529874B2 (ja) | 2014-06-25 |
KR101368736B1 (ko) | 2014-03-05 |
US20130324500A1 (en) | 2013-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0913697A2 (pt) | lesão de medula, inflamação e doença auto-imuni: agentes teraupêuticos de liberação local controlada. | |
BRPI1016199A2 (pt) | cobertura de ferimento e kit de tratamento de ferimentos. | |
IL189843A0 (en) | Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators | |
BR112012004792A2 (pt) | dispositivo cirúrgico e acessórios. | |
BRPI0820212A2 (pt) | Dispositivo para tratamento de fraturas, método para tratamento de fraturas, e, kit para tratamento de fraturas | |
EP2134078A4 (en) | PICTURE DEVICE AND ENDOSCOPE | |
BRPI0813212A2 (pt) | Métodos de tratamento de doenças e distúrbios mediados por serotonina | |
BRPI0813725A2 (pt) | Métodos e composições para tratamento de doenças | |
BRPI0921919A2 (pt) | dispositivos médicos, aparelhos, sistemas e métodos | |
FR2937853B1 (fr) | Dispositif portatif de diagnostic de la peau. | |
BRPI0922758A2 (pt) | instrumento cirúrgico, cabo para instrumento cirúrgico e sistema de instrumento cirúrgico. | |
BRPI0811846A2 (pt) | Implante vertebral interespinhal, e, dispositivo | |
BRPI0817870A2 (pt) | dispositivo para tratamento de aneurisma | |
PL2376537T3 (pl) | Ludzkie przeciwciała przeciwko ludzkiemu czynnikowi tkankowemu | |
BRPI0812384A2 (pt) | Métodos de tratamento, diagnóstico e detecção de distúrbios associados a fgf21 | |
BRPI0916125A2 (pt) | "dispositivo de tratamento" | |
BRPI0911666A2 (pt) | sistema para cirurgia oftalmológica refrativa. | |
BRPI0919794A2 (pt) | dispositivo para uso intracorpóreo, e, composto | |
BRPI0813364A2 (pt) | Métodos de diagnóstico e tratamento de câncer. | |
HK1115798A1 (en) | Skin care device | |
HK1137135A1 (en) | Skin care device | |
DE602005021084D1 (de) | ENDOSKOPisches BEHANDLUNGSSYSTEM | |
EP2116255A4 (en) | MEANS FOR THE TREATMENT OF BACKBREAK INJURIES | |
BRPI0807804A2 (pt) | " arilciclopentenos substituídos como agentes terapêuticos ". | |
BRPI0822898A2 (pt) | Dispositivo de interface de usuário, método para iluminar o dispositivo de interface de usuário e dispositivo de interface |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15I | Others concerning applications: loss of priority |
Free format text: PERDA DA PRIORIDADE US 61/100,127B E 25/09/2008 REIVINDICADA CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 7O, ITEM 28 DO ATO NORMATIVO 128/97 E NO ART. 29 DA RESOLUCAO INPI-PR 77/2013. ESTA PERDA SE DEU PELO FATO DE O DEPOSITANTE CONSTANTE DA PETICAO DE REQUERIMENTO DO PEDIDO PCT (INVIVO THERAPEUTICS CORPORATION) SER DISTINTO DAQUELE QUE DEPOSITOU A PRIORIDADE REIVINDICADA E NAO APRESENTOU DOCUMENTO COMPROBATORIO DE CESSAO, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 6O, ITEM 27 DO ATO NORMATIVO 128/97 E NO ART. 28 DA RESOLUCAO INPI-PR 77/2013. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B12F | Other appeals [chapter 12.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |